Abstract:G protein-coupled receptors (GPCRs) represent the largest family of membrane proteins and are important drug targets. GPCRs are allosteric machines that transduce an extracellular signal to the cell by activating heterotrimeric G proteins. Herein, we summarize the recent advancements in the molecular activation mechanism of the c-aminobutyric acid type B (GABAB) and metabotropic glutamate (mGlu) receptors, the most important class C GPCRs that modulate synaptic transmission in the brain. Both are mandatory dimers, this quaternary structure being needed for their function The structures of these receptors in different conformations and in complexes with G proteins have revealed their asymmetric activation. This asymmetry is further highlighted by the recent discovery of mGlu heterodimers, where the eight mGlu subunits can form specific and functional heterodimers. Finally, the development of allosteric modulators has revealed new possibilities for regulating the function of these receptors by targeting the transmembrane dimer interface. This family of receptors never ceases to astonish and serve as models to better understand the diversity and asymmetric functioning of GPCRs. NEW & NOTEWORTHY c-aminobutyric acid type B (GABAB) and metabotropic glutamate (mGlu) receptors form constitutive dimers, which are required for their function. They serve as models to better understand the diversity and activation of G protein-coupled receptors (GPCRs). The structures of these receptors in different conformations and in complexes with G proteins have revealed their asymmetric activation. This asymmetry is further highlighted by the recent discovery of specific and functional mGlu heterodimers. Allosteric modulators can be developed to target the transmembrane interface and modulate the asymmetry.

Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembrane interface

Allosteric Control of an Asymmetric Transduction in a G Protein-Coupled Receptor Heterodimer.

Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.

Positive allosteric modulation of a GPCR ternary complex

Concerted Conformational Changes Control Metabotropic Glutamate Receptor Activity.

Structural Basis of Orientated Asymmetry in a Mglu Heterodimer

Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.

Asymmetric activation of dimeric GABAB and metabotropic glutamate receptors

G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding.

Structural basis of positive allosteric modulation of metabotropic glutamate receptor activation and internalization

Pharmacologically Targeting Intracellular Allosteric Sites of GPCRs for Drug Discovery.

Delineating the stepwise millisecond allosteric activation mechanism of the class C GPCR dimer mGlu5

An Allosteric Ligand Stabilizes Distinct Conformations in the M2 Muscarinic Acetylcholine Receptor

Allosterism in the adenosine A2A and cannabinoid CB2 heteromer

Design of allosteric modulators that change GPCR G protein subtype selectivity

Allosteric functioning of dimeric class C G-protein-coupled receptors.

Molecular Insights into Ago-Allosteric Modulation of the Human Glucagon-Like Peptide-1 Receptor

Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1

Determination of the Cannabinoid CB1 Receptor's Positive Allosteric Modulator Binding Site through Mutagenesis Studies

GPCR Allostery: A View from Computational Biology.